NorthWest Biotherapeutics Inc (NWBO)

[kabunushi]

The exec comp isn't even about 2022 nor even 2021. This is about $27M worth of options to the top 2 for 2018-2020. IMO just not enough progress after 95% of shareholders' equity was crushed out of the stock and not yet recovered as of year-end 2020. It's about massive option awards at the complete bottom price of the shares. That collapse of the shares may not in all fairness be only management's fault but they still ought to be held to account for that rather than be so obscenely well rewarded, IMO.

I will vote No on exec comp but I'm sure it will get approved. Then I fully expect more large awards to be granted for 2021-2022. Maybe not but it will be a big surprise to me if they don't come back to the well. IMO don't reward non-performance. If and when they do get RA approvals we can reward them then rather than awarding a gazillion options granted at the historic bottom share price which they ought to take some responsibility for!